The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.
17-Oct-2016 - Premier Research has become the most recent contract research organization (CRO) to receive funding from private equity as the industry looks for "like-minded" partners for the long run.
12-Oct-2016 - In a year of “merger mania,” researchers suggest the elimination of competition is reducing innovation in the pharmaceutical industry.
26-Sep-2016 - Parexel has entered into a definitive agreement to acquire ExecuPharm, a global functional service provider (FSP), in a deal that it said will add scale to meet growing demand.
19-Sep-2016 - The acquisition, which was announced in June of this year, has been completed, expanding the company’s reach into government sponsored research.
25-Aug-2016 - Currently, the top ten CROs represent more than half the market, and as the industry continues to grow analysts suggest companies expand revenue streams through “nontraditional” services offerings.
22-Aug-2016 - The international private equity firm, Cinven, is set to purchase Bioclinica, marking the company’s latest in a series of purchases as industry consolidation continues.
13-Jul-2016 - The independent lab network has combined 11 of its brands, including ABC Laboratories, to reside under a single company in order to “leverage cross functional capabilities,” says CEO.
28-Jun-2016 - Charles River Laboratories has acquired Blue Stream Laboratories, expanding the company’s biologic and biosimilar development capabilities.
02-Jun-2016 - Partners Group, a private markets investment manager, has agreed to acquire global pharmaceutical services provider PCI Pharma Services citing “trends towards outsourcing.”
11-May-2016 - After reporting a successful FY16, Charles River expects a successful new year driven by customer demand and enhanced strategic partnerships.
21-Apr-2016 - Aptuit has acquired Swiss CRO Exquiron Biotech, enhancing its drug identification and validation services.
04-Apr-2016 - International Chemical Investors Group (ICIG) has completed its acquisition of Sandoz Industrial Products GmbH from Novartis Group.
15-Mar-2016 - The flexible manufacturing deal with Amgen is a departure from the standard transactional contract approach, according to Patheon.
09-Mar-2016 - Crown Bioscience has announced the acquisition of PreClinOmics, an in vivo preclinical company specializing in early research in cardiovascular and metabolic diseases (CVMD).
07-Mar-2016 - Synexus has bought trial site network Research Across America (RAA) in a deal it claims will give its customers access to the US market and additional study participants.
16-Feb-2016 - The generic pharmaceuticals company, Mylan, has announced its offer to buy the Swedish specialty pharma company, Meda, in a deal valued at $9.9 bn.
27-Jan-2016 - French CDMO Amatsigroup will offer complete biologics development services and expand its European presence through the acquisition of Q Biologicals.
05-Jan-2016 - Mergers among Big Pharma companies will continue into 2016 leaving strategic CRO partnerships at risk, according to a report from PwC.
25-Nov-2015 - As CMOs wait to see the short-term fallout of the Pfizer-Allergan deal, an M&A expert says contract manufacturing will follow the CRO industry in embracing strategic alliances and consolidation....
24-Nov-2015 - Charles River has acquired German preclinical CRO Oncotest GmbH in a €34m ($36m) cash deal.
05-Nov-2015 - Gaining a foothold in North America would complete Recipharm’s growth strategy in becoming a global CDMO leader, the firm says.
05-Nov-2015 - CMO consolidation strategy has shifted from building scale and adding geographies towards niche technologies and biologics, according to the founder of trade association PBOA.
02-Nov-2015 - Parexel has lowered its revenue guidance for the year following cancellations worth $305m in its first quarter FY2016.
30-Oct-2015 - The fight between CROs for clinical research associates (CRAs) and people with certain other skillsets is hotting up, with both Icon and Quintiles identifying it as an issue faced by...
29-Oct-2015 - Reports Pfizer is considering buying Allergan to create a company worth $330bn have once again raised fears of disruption for contract research organisations (CRO), although there are reasons to think...